Webinar: COVID-19 Health Disparities, Respiratory Illness, and Communities of Color
Webinar: COVID-19 Health Disparities, Respiratory Illness, and Communities of Color
Originally recorded October 7, 2020 | 11:00 AM - 12:00 PM CT
ABOUT
As the global COVID-19 pandemic has gripped the world, crucial health inequity concerns are already emerging. While health disparities for marginalized communities are not new, the pandemic has thrust health disparities and systemic health inequities to the forefront of the national health conversation. Recently released data from the non-partisan APM Research Lab indicate that African Americans are dying from COVID-19 at almost three times the rate of white Americans. Furthermore, COVID-19 health disparities are driven in large part to highly-prevalent, chronic conditions, such as cardiovascular disease, respiratory disorders, and diabetes, that disproportionately impact communities of color. Chronic respiratory illnesses also make COVID-19 particularly dangerous. Respiratory health has seen inequality for years, both in the prevalence of respiratory diseases in marginalized patient groups as well as access to care. Respiratory diseases such as asthma, lung diseases, and pulmonary hypertension are the third-leading cause of death in America, and they are some of the costliest diseases for those affected. Furthermore, according to the 2015 Kelly Report on Health Disparities in America, African-American children suffer the highest-burden of asthma with more than 16 percent of children likely to have asthma compared to Hispanic (9 percent) or non-Hispanic White (8 percent) children, and the prevalence of asthma is increasing among low-income minority children. This webinar brings together leading respiratory illness experts to discuss systemic inequities and social determinants of health that make communities of color more susceptible to respiratory illness as well as discuss best practices to address these disparities.
Distinguished Webinar Leaders
Key Statistics and Infographics
Webinar Leaders
Ms. Lynn Hanessian
CHI Board of Directors
Chief Strategist at Edelman
Dr. Susan Corbridge, Ph.D.
Clinical Professor, Department of Medicine, Division of Pulmonary, Critical Care, Allergy & Sleep Medicine at UI Health
Mr. Kenneth Mendez
CEO & President of the Asthma and Allergy Foundation of America
Joseph Gaspero is the CEO and Co-Founder of CHI. He is a healthcare executive, strategist, and researcher. He co-founded CHI in 2009 to be an independent, objective, and interdisciplinary research and education institute for healthcare. Joseph leads CHI’s research and education initiatives focusing on including patient-driven healthcare, patient engagement, clinical trials, drug pricing, and other pressing healthcare issues. He sets and executes CHI’s strategy, devises marketing tactics, leads fundraising efforts, and manages CHI’s Management team. Joseph is passionate and committed to making healthcare and our world a better place. His leadership stems from a wide array of experiences, including founding and operating several non-profit and for-profit organizations, serving in the U.S. Air Force in support of 2 foreign wars, and deriving expertise from time spent in industries such as healthcare, financial services, and marketing. Joseph’s skills include strategy, management, entrepreneurship, healthcare, clinical trials, diversity & inclusion, life sciences, research, marketing, and finance. He has lived in six countries, traveled to over 30 more, and speaks 3 languages, all which help him view business strategy through the prism of a global, interconnected 21st century. Joseph has a B.S. in Finance from the University of Illinois at Chicago. When he’s not immersed in his work at CHI, he spends his time snowboarding backcountry, skydiving, mountain biking, volunteering, engaging in MMA, and rock climbing.